NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

William Blair Starts Coverage on Vertical Aerospace With Bullish View

William Blair begins coverage of Vertical Aerospace with an Outperform rating, highlighting its strong position in the growing urban air mobility market.

William Blair Starts Coverage on Vertical Aerospace With Bullish View
Credit: Vertical Aerospace
Already have an account? Sign in.
01/07/2026 · 11:32 AM
EVTL
/ Don’t stop at just one post.

Related↓

Raymond James Downgrades Vertical Aerospace to Underperform – Funding Worries Grow
02/23/2026 · 7:58 AM

Raymond James Downgrades Vertical Aerospace to Underperform – Funding Worries Grow

Raymond James downgrades Vertical Aerospace to Underperform due to cash runway concerns through mid-June and rising competition for talent from Archer's new Bristol hub.

/ Subscriber only
/ Read more

Feed↓

CVC Weighs €9bn Bid to Take Italy’s Nexi Private
Featured/ 04/28/2026 · 12:35 PM

CVC Weighs €9bn Bid to Take Italy’s Nexi Private

CVC Capital Partners may buy Nexi for €9B, but faces political hurdles and weak business performance.

/ Subscriber only
Pfizer Delays Generic Vyndamax Until 2031 – Great News for BridgeBio’s Attruby
Featured/ 04/28/2026 · 10:07 AM

Pfizer Delays Generic Vyndamax Until 2031 – Great News for BridgeBio’s Attruby

Pfizer extends Vyndamax patent to 2031, delaying generics and giving BridgeBio more time to grow its rival heart drug without pressure.

/ Subscriber only
Rocket Scores $180 Million Cash Boost – Extends Runway to 2028 for Heart Gene Therapies
04/28/2026 · 9:29 AM

Rocket Scores $180 Million Cash Boost – Extends Runway to 2028 for Heart Gene Therapies

Rocket Pharma sold an FDA voucher for $180M cash, boosting funds without dilution and extending runway to 2028 for heart gene therapies.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe